OverviewSuggest Edit
Evotec is a drug discovery alliance and development partnership company. It provides pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capital firms with drug discovery solutions in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates, and consulting arrangements. The company specializes in the areas of neuroscience, diabetes, and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases, and fibrosis.
| Type | Public | |
| Founded | 1993 | |
| HQ | Hamburg, DE | Map |
| Website | evotec.com | |
| Employee Ratings | More |
Recent NewsAll News
- Evotec partners with CEBINA to launch Danube Labs, a partnership to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities and Research Institutions
- Autobahn Labs incubator announces partnership with Cold Spring Harbor Laboratory to advance novel science to the clinic
- Evotec SE reports results for the first quarter 2021 and provides corporate update
- Evotec launches "beLAB1407" to accelerate translational research from the UK's academic life science ecosystem in collaboration with Bristol Myers Squibb
Key People/Management at Evotec
Werner Lanthaler
Craig Johnstone
Enno Spillner
Cord Dohrmann
Volker Braun
Wolfgang Plischke
Evotec Office Locations
Evotec Financials and Metrics
Evotec Revenue
| EUR | |
|---|---|
Revenue (FY, 2020) | 509.9m |
Revenue growth (FY, 2019 - FY, 2020), % | 14.2% |
Gross profit (FY, 2020) | 134.7m |
Gross profit margin (FY, 2020), % | 26.4% |
Net income (FY, 2020) | 6.3m |
EBIT (FY, 2020) | 48.5m |
Market capitalization (11-Jun-2021) | 5.8b |
Closing stock price (11-Jun-2021) | 35.3 |
Cash (31-Dec-2020) | 422.6m |
EV | 5.9b |
| EUR | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 79.0m | 94.8m | 96.3m | 103.8m | 103.2m | 114.3m | 119.4m | 111.6m | 129.4m |
Cost of goods sold | 60.5m | 63.0m | 62.9m | 72.2m | 71.1m | 79.3m | 86.1m | 91.8m | 93.3m |
Gross profit | 18.5m | 31.8m | 33.4m | 31.7m | 32.1m | 35.0m | 33.3m | 19.8m | 36.1m |
Gross profit Margin, % | 23% | 34% | 35% | 30% | 31% | 31% | 28% | 18% | 28% |
| EUR | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Cash | 57.4m | 91.3m | 135.1m | 111.6m | 322.3m | 249.6m | 285.4m | 224.4m | 215.9m |
Accounts Receivable | 44.3m | 46.0m | 48.9m | 48.8m | 51.6m | 51.8m | 68.2m | 90.8m | 94.4m |
Inventories | 6.1m | 5.3m | 6.7m | 5.6m | 6.5m | 12.2m | 10.9m | 10.6m | 11.7m |
Current Assets | 175.3m | 207.8m | 274.0m | 254.6m | 464.1m | 410.1m | 464.6m | 445.6m | 427.2m |
| EUR | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 3.5m | 17.9m | 52.3m | 13.1m | 10.7m | 29.7m | 17.1m | 7.3m | 5.8m |
Cash From Operating Activities | 4.1m | 71.2m | 128.7m | (13.1m) | (11.0m) | 1.2m | 27.1m | (7.0m) | 20.8m |
Purchases of PP&E | (6.2m) | (2.7m) | (20.7m) | (5.8m) | (14.4m) | (20.4m) | (16.3m) | (28.7m) | (55.3m) |
Cash From Investing Activities | (7.5m) | (13.6m) | (17.9m) | 3.7m | 5.4m | (58.6m) | (13.5m) | (53.2m) | (82.9m) |
| EUR | FY, 2017 |
|---|---|
Debt/Equity | 0.6 x |
Debt/Assets | 0.3 x |
Financial Leverage | 2 x |
Evotec Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Just-Evotec Biologics | May 20, 2019 | $90 m |
| Aptuit | July 30, 2017 | $300 m |
| Cyprotex | October 26, 2016 | £55.7 m |
| Euprotec | May 28, 2014 | $3.2 m |
| Bionamics GmbH | March 24, 2014 | |
| Cell Culture Service GmbH | January 03, 2013 | €1.2 m |
| Compound Focus | June 01, 2011 | |
| KINAXO Biotechnologies | April 19, 2011 | |
| Develogen AG | July 14, 2010 | |
| Evotec (India) Private Ltd | August 31, 2009 |
Evotec Revenue Breakdown
Evotec revenue breakdown by business segment: 77.9% from EVT Execute and 22.1% from EVT Innovate
Evotec revenue breakdown by geographic segment: 18.8% from United Kingdom, 7.4% from France, 49.5% from Unites States, 15.5% from Others and 8.8% from Germany
Evotec Cybersecurity Score
Evotec Environment, Social & Governance (ESG) Ratings
Evotec Online and Social Media Presence
2.76k Twitter followers
Evotec has 2.76k Twitter Followers. The number of followers has increased 1.4% month over month and increased 9.7% quarter over quarter
Evotec's Trends
Twitter Engagement Stats for @Evotec
1.9k
Tweets
128
Following
2.8k
Followers
24
Tweets last 30 days
4.4
Avg. likes per Tweet
100%
Tweets with engagement
Evotec News and Updates
Evotec partners with CEBINA to launch Danube Labs, a partnership to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities and Research Institutions
Autobahn Labs incubator announces partnership with Cold Spring Harbor Laboratory to advance novel science to the clinic
Evotec SE reports results for the first quarter 2021 and provides corporate update
Evotec launches "beLAB1407" to accelerate translational research from the UK's academic life science ecosystem in collaboration with Bristol Myers Squibb
Evotec SE to announce results for the first quarter 2021 on 11 May 2021
Evotec and the GCKD study enter into strategic collaboration to build a unique molecular patient database
Evotec Frequently Asked Questions
When was Evotec founded?
Evotec was founded in 1993.
Who are Evotec key executives?
Evotec's key executives are Werner Lanthaler, Craig Johnstone and Enno Spillner.
How many employees does Evotec have?
Evotec has 3,572 employees.
What is Evotec revenue?
Latest Evotec annual revenue is €509.9 m.
What is Evotec revenue per employee?
Latest Evotec revenue per employee is €142.8 k.
Who are Evotec competitors?
Competitors of Evotec include Eurofins, WuXi Biologics and Actelion Pharmaceuticals.
Where is Evotec headquarters?
Evotec headquarters is located at Essener Bogen 7, Hamburg.
Where are Evotec offices?
Evotec has offices in Hamburg, Göttingen, Köln, Planegg and in 8 other locations.
How many offices does Evotec have?
Evotec has 12 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies